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Aim of the study: Previous studies have shown that the extracts obtained from Tropaeolum majus L. exhibit
pronounced diuretic properties. In the present study, we assessed whether the hypotensive and/or anti-
hypertensivemechanismof hydroethanolic extract (HETM), semi-puriﬁed fraction (TMLR) obtained from
T. majus and the ﬂavonoids isoquercitrin (ISQ) and kaempferol (KPF) can be mediated by their interaction
with angiotensin converting enzyme (ACE).
Methods and methods: Firstly, to evaluate changes in mean arterial pressure (MAP), different groups of
normotensive and spontaneously hypertensive rats (SHR) were orally and intraduodenally treated with
HETM (10–300mg/kg) and TMLR (12.5–100mg/kg) and intravenously treated with ISQ and KPF being
later anesthetizedwith ketamine (100mg/kg) and xylazine (20mg/kg). The left femoral vein and the right
carotid artery were isolated, and polyethylene catheters were inserted for ISQ and KPF (0.5–4mg/kg)
administration and blood pressure recording, respectively. The plasmatic ACE activity was evaluated to
indirect ﬂuorimetry, in serum samples after orally treatment with HETM, TMLR, ISQ and KPF.
Results: The oral administration of the HETM and its TMLR signiﬁcantly reduced, in a dose-dependent
manner, the MAP in both normotensive and SHR. In addition, these preparations signiﬁcantly decreased
theMAP for up to 3h after the administration of the extract. Additionally, the intravenous administration
of ISQ, but not KPF, decreased MAP in rats. Otherwise, neither the extracts nor ISQ affected the heart rate.
The oral administration of the HETM, TMLR or ISQ reduced ACE activity in serum samples at 90min
after administration. Finally, the intravenous administration of ISQ caused a signiﬁcant reduction in the
hypertensive response to angiotensin I, but not angiotensin II in normotensive rats.
Conclusion: Our results show that the hypotensive effects caused by the HETM, as well as by its TMLR,
he hig
eventmay be associated with t
hypotension in rats is an
. IntroductionCardiovascular disease manifests in a number of clinically
elevant ways, affecting a large segment of the world’s adult
opulation (Zhang et al., 2006). Patients with a blood-pressure
easure of 140/90mmHg (systolic/diastolic pressure) are typically
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Open access under the Elsevier OA license. h levels of the ﬂavonoid ISQ found in this plant. In addition, ISQ-induced
dependent on the inhibition of angiotensin II generation by ACE.
© 2010 Elsevier Ireland Ltd. 
regarded as having high blood pressure, as deﬁned in guidelines.
Hypertension also involves complex structural and functional
alterations in target organs. In the hypertensive state, a number
of adaptive changes occur in blood vessels, leading to endothelial
dysfunction and an increase in the extracellular matrix (Addison
et al., 2008). Common clinical strategies to achieve a lowering
of blood pressure include the use of beta adrenergic antagonists,
calcium channel blockers, diuretics, angiotensin II type I receptor
Open access under the Elsevier OA license. antagonists and angiotensin converting enzyme (ACE) inhibitors
(Williams et al., 2004).
Inhibition of ACE has been a highly successfully program in the
pharmaceutical industry, resulting in a class of effective antihyper-
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ensive drugs. In fact, synthetic ACE inhibitors such as captopril and
nalapril are widely used for the treatment of cardiovascular and
enal disease, for the secondary prevention of coronary artery dis-
ase, and for heart failure (Pfeffer and Frohlich, 2006). However,
ide effects such as cough, angioneurotic edema and deleterious
ffects in pregnancy have been associated with the clinical use of
CE inhibitors (Israili and Hall, 1992; Opie, 1996).
A number of extracts and compounds obtained fromplants have
een identiﬁed as in vitro ACE inhibitors (Nyman et al., 1998; Park
t al., 2003). Nevertheless, only a few studies on ACE inhibitory
ctivity underlying the hypotensive and antihypertensive effects
f plant species have been reported.
Flavonoids are ubiquitously distributed throughout nature,
specially in certain plants, and are often utilized in folk medicine
n many countries. The ﬁnding that the consumption of certain
avonol-rich foods can mediate a reduction in blood pressure
aises the possibility that ﬂavonolsmay act as pharmacological ACE
nhibitors. Several studies have shown that someﬂavonoids exhibit
n vitro ACE inhibition (Emura et al., 2007; Lacaille et al., 2001;
chrammandGerman,1998;WuandMuir, 2008). In addition, it has
een shown that some ﬂavonoids also possess other relevant phar-
acological properties, such as antioxidant and cardioprotective
ctions (Wu and Muir, 2008).
Tropaeolum majus L. (Tropaeolaceae), popularly known as
chaguinha”, is well-recognized in traditional medicine as hav-
ng cardiovascular and renal effects (Ferreira et al., 2004; Ferro,
006; Lorenzi and Matos, 2002), although no scientiﬁc data have
een published to support these effects. Previous ﬁndings from our
esearch group have shown that extract from Tropaeolum majus
xhibit has important in vivo diuretic properties (Gasparotto Junior
t al., 2009). In relation to potential cardiovascular activities, exper-
mental studies indicated potential antithrombin (De Medeiros
t al., 2000) and in vitro ACE inhibitor activities (Han et al., 1991).
In the present study, we have further investigated the pres-
nce of isoquercitrin and kaempferol in a hydroethanolic extract
HETM) and semi-puriﬁed fraction (TMLR) from Tropaeolum majus
nd whether or not the hypotensive/antihypertensive actions of
he HETM, TMLR, isoquercitrin and kaempferol are associated with
heir ability to inhibit ACE in vivo.
. Materials and methods
.1. Drugs
N-hippuryl-l-histidyl-l-leucine hydrate, o-phthalaldehyde,
ngiotensin I, bradykinin, isoquercitrin and kaempferol were
btained from Sigma (St. Louis, MO, USA). Captopril from Sigma
St. Louis, MO, USA) was used as the reference ACE inhibitor drug.
ther drugs and reagents used were of analytical grade.
.2. Phytochemical studies
.2.1. Plant material and preparation of the HETM and TMLR
Tropaeolum majus leaves were collected in June 2008 from the
otanical gardenofUniversidadeParanaense (UNIPAR), Umuarama
Brazil) at 430mabove sea level (S23◦47′55–W53◦18′48). Theplant
as identiﬁed by Dr. Mariza Barion Romagnolo (Department of
otany, Universidade Paranaense, PR, Brazil). Voucher specimens
ere deposited at the Herbarium of this University under number
230. Crude ethanolic extract (HETM) and fraction (TLMR) were
btained as previously described (Gasparotto Junior et al., in press).
rieﬂy, the extraction with ethanol 90% yielded HETM, which was
ubmitted to a column with Amberlite XAD-2 to give TLMR. Both
amples were dissolved in distilled water immediately prior to
dministration.pharmacology 134 (2011) 363–372
2.2.2. Phytochemical analysis
HETM and TLMR were analyzed by HPLC and ESI-MS using the
same equipments previously reported (Gasparotto Junior et al., in
press). HETM and TMLR were dissolved in a solution containing
50% (v/v) chromatographic grade methanol and 50% (v/v) deion-
ized water with 0.5% ammonium hydroxide (Merck, Darmstadt,
Germany). In the ﬁngerprinting ESI-MS analysis, the general con-
ditions were as follows: source temperature of 100 ◦C; capillary
voltage of 3.0 kV; and cone voltage of 30V. Formeasurements in the
negative ion mode, ESI(−)-MS, 10L of concentrated NH4OH were
added to the sample mixture (having a total volume of 1000L),
yielding 0.1% as ﬁnal concentration. ESI-MS was preformed by
direct infusion with a ﬂow rate of 10LminmL−1 using a syringe
pump (Harvard Apparatus). Structural analysis of single ions in
the mass spectra from extract and fraction was performed by ESI-
MS/MS. The ionwith them/z of interestwas selected and submitted
to 15–45eV collisions with argon in the collision quadrupole. The
collision gas pressure was optimized to produce extensive frag-
mentation of the ion under investigation. The compounds were
identiﬁed by comparison of their ESI-MS/MS fragmentation spectra
with literature data (Roesler et al., 2008; Ye et al., 2007). In addi-
tion the chemical composition of HETM and the TMLR were also
determined by HPLC-UV using comparative analysis using isolated
standards. A volume of 10L of each sample was injected into the
RP-18 (Lichrospher®, Merck KGaA, Darmstadt, Germany) column
(5m, 225mm×4.6mm i.d.) protected by a RP-18 guard column
from Merck (5m, 4.0mm×3.0mm i.d.). The mobile phase con-
sisted of a linear gradient combining solvent A (acetonitrile) and
solvent B (water/acetic acid, 99:1, v/v, pH 2.88) as follows: 15%
A (15min), 15–20% A (7min), 20% A (5min), 20–40% A (5min),
40% A (5min), 40–15% A (5min). The analyses were carried out in
triplicate, at a ﬂow rate of 0.6mL/min and peak areas were calcu-
lated by a Shimadzu CLASS-VPTM 7.2.1. For the bioactive compound
isoquercitrin, HPLC quantitative analysis was performed (Li et al.,
2008).
2.2.3. Quantitative HPLC analysis of isoquercitrin
In order to prepare standard solutions, isoquercitrin standard
was dissolved in methanol/water (1:1, v/v). Serial concentrations
of this ﬂavonoid were prepared at eight concentrations, from 1 to
20g/mL. Quantitative HPLC analyses were conducted using the
same conditions described above. The analyses were carried out
in triplicate, at a ﬂow rate of 0.6mL/min with the UV detector set
at  330nm and an injection volume of 10L. Calibration graphs
were plotted showing a linear relationship between concentrations
versus peak areas for the reference compound.
Accurately weighed amounts of the HETM and TMLR were
dissolved in methanol/water (1:1) and analyzed using the same
chromatographic conditions as used for isoquercitrin. The attribu-
tion of the chromatographic peak was based on the retention times
of the single compound and conﬁrmed by analysis in comparison
with the isolated standard.Underourworking conditions, themean
of retention time for isoquercitrin was 33.75min. The concentra-
tion of the isoquercitrinwas calculated from the experimental peak
area by analytical interpolation on a standard calibration line. The
limit of quantiﬁcation (LOQ) for the compound analyzed was the
1.25g/mL.
2.3. Pharmacological studies
2.3.1. Animals
We used male Wistar rats (3–4 months old, weighing between
250 and 300g) from the colony of the Universidade Federal do
Paraná. Wistar–Kyoto (WKY) and spontaneously hypertensive rats
(SHR) were obtained from Biomedical Science Institute of the
Universidade de São Paulo (USP), Brazil. All animals were main-
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ained under standard laboratory conditions, with a constant 12h
ight/dark cycle and controlled temperatures (22±2 ◦C). Standard
ellet food (Nuvital®, Curitiba/PR, Brazil) and water were available
d libitum. All experimental procedures adopted in this study were
reviously approved by the Institutional Ethics Committee of the
niversidade Federal do Paraná (authorization number 240).
.3.2. Direct blood pressure and heart rate measurement in
nesthetized rats
Normotensive male Wistar rats, WKY or SHR were anesthetized
ith ketamine (100mg/kg) and xylazine (20mg/kg), adminis-
ered intramuscularly and supplemented at 45–60min intervals.
polyethylene catheter was inserted into the right femoral vein
or ﬂavonoids and drug administration. Immediately after venous
annulation, a bolus injection of heparin (30 IU) was administered
.v. Animals were allowed to breath spontaneously through a tra-
heotomy. The left carotid artery was cannulated and connected to
pressure transducer coupled to a PowerLab® recording system,
nd an application program (Chart, v 4.1; all from ADI Instruments;
astle Hill, Australia) recorded both mean arterial pressure (MAP)
nd heart rate (HR). For stabilization of the blood pressure after the
urgical process, an interval of 15minwas held before the injection
f any drug. At the endof the experiments, animalswere killedwith
n overdose of thiopental (over 40mg/kg, i.v.).
.3.3. Experimental protocols
.3.3.1. Hypotensive dose response and time course of HETM
nd TMLR obtained from Tropaeolum majus. Different groups
f normotensive rats received orally (10–300mg/kg), TMLR
12.5–100mg/kg) or the vehicle via an oral route, at a constant
olume of 100L/100g body weight. MAP and HR values for each
nimal were recorded after 1.5, 3, 6 and 12h of treatment. Each
nimal received only one of the substances studied.
.3.3.2. Evaluation of antihypertensive effects of HETM and TMLR
btained fromTropaeolummajus. GroupsofWKYandSHR,prepared
or direct blood pressure measurements as previously described,
eceived intraduodenally HETM or TMLR at 100 and 50mg/kg,
espectively. The control group received the vehicle intraduode-
ally at a constant volume of 100L/100g of body weight. The
hanges in MAP and HR were recorded for 45min after these treat-
ents.
.3.3.3. Evaluation of hypotensive effects of isoquercitrin and
aempferol. Differentgroupsof animals received intravenous injec-
ions of isoquercitrin (ISQ) or kaempferol (KPF), at 0.5, 1, 2 and
mg/kg. Administration of these ﬂavonoids was done randomly, at
constant volume of 100L/100g (body weight). Each animal was
ested for only one of the ﬂavonoids studied.
.3.3.4. Angiotensin converting enzyme (ACE) assay. ACE activity
as determined in serum plasma obtained from normotensive,
ale Wistar rats (250–300g) 1.5h after oral treatment with capto-
ril (20mg/kg), HETM (30–300mg/kg), TMLR (25–100mg/kg), iso-
uercitrin and kaempferol (5–10mg/kg), as previously described
Santos et al., 1985). The control group received vehicle at a con-
tant volume of 100L/100g of body weight. Blood was collected
nto glass tubes after decapitation, and serum was separated after
h at 37 ◦C. Brieﬂy, serum (10L) was incubated with 490L of
ssay solution containing5mMHip-His-Leu in0.4Msodiumborate
uffer, pH 8.3, and 0.9M NaCl for 15min at 37 ◦C. The reaction
as stopped by addition of 1.2mL of NaOH 0.34N. The prod-
ct, His-Leu, was measured ﬂuorometrically (365nm excitation
nd 495 emission, AmincoModel J4-7461 ﬂuoromonitor, American
nstrument Co., Silver Springs, MD) after the addition of 100L of
-phthaldialdehyde (20mg/ml) in methanol, which was followedpharmacology 134 (2011) 363–372 365
10min later by the addition of 200L of HCl 3N and centrifugation
at 800× g for 5min at room temperature. To correct the intrinsic
ﬂuorescenceof theplasma, time-zeroblank sampleswereprepared
by adding plasma after NaOH treatment. Captopril was used as a
positive control. All measurements were made in triplicate.
2.3.3.5. Evaluation of isoquercitrin inﬂuence in angiotensin I and
bradykinin-induced changes inMAP. After cannulation andMAPsta-
bilization, the effects of angiotensin I (10pmol/kg, i.v.), bradykinin
(30nmol/kg, i.v.) and isoquercitrin (4mg/kg, i.v.) on the mean
arterial pressure were recorded. After the administration of iso-
quercitrin, the injection of angiotensin I and bradykinin was
repeated for comparison. An interval of 15min between each
administration was maintained.
2.4. Statistical analysis
Data for quantitative HPLC analysis are reported as means (per-
cent of relative standard deviation) of triplicate determinations.
The changes in the MAP are expressed as mean± standard error
of the mean of six experiments. Statistical signiﬁcance was deter-
mined using one-way analysis of variance (ANOVA) followed by
Bonferroni’s test or Student’s t-test, when applicable. A p-value less
than 0.05 was considered to be statistically signiﬁcant. The graphs
were drawn, and the statistical analyses were performed using
GraphPadPrismversion5.01 forWindows (GraphPadSoftware, San
Diego, CA).
3. Results
3.1. Phytochemical analysis
The ESI-MS ﬁngerprints of the HETM and TMLR in the negative
mode (Fig. 1) showed characteristic distributions of the ﬂavonoids
isoquercitrin (m/z 464) and kaempferol glucoside (m/z 448), which
were detected as the deprotonated molecules of m/z 463 and 447,
respectively, and identiﬁed by comparison with data found in the
literature (Roesler et al., 2008). These results were conﬁrmed by
HPLC-UV analysis using isolated standards, and the structureswere
unequivocally conﬁrmed by co-injection of authentic standards
and identiﬁed by retention values (Fig. 2).
The HPLC quantitative method was validated for isoquercitrin
(Gaskell, 1997), and the content of this compound in the HETM and
in the TMLRwas 3.86% and9.35%, respectively (Table 1). This chem-
ical results for Tropaeolummajuswas recently reported (Gasparotto
Junior et al., in press).
3.2. Hypotensive effects of HETM and TMLR in normotensive rats
The basal MAP recorded in anesthetized control rats, after the
15min period allowed for stabilization, was 113.5±2.4mmHg.
The oral administration of HETM (10 and 300mg/kg), after 1.5h
of treatment caused a signiﬁcant reduction (∼13mmHg) in MAP,
in a dose and time-dependent manner (Fig. 3A and B). A signif-
icant decrease in the mean arterial pressure was observed up to
3h after the administration of the extract (Fig. 3B). Similarly, the
oral administration of TMLR (12.5 and 100mg/kg) was able to
induce dose-dependent hypotensive effects (Fig. 3C), with values
of reduction of 17.94±4.70 and 20.77±5.43mmHg, respectively.
At least in the range of doses used in our experiments, neither
HETM nor TMLE were able to signiﬁcantly reduce the heart rate
of anesthetized normotensive rats (Table 2).3.3. Antihypertensive effect of HETM and TMLR in SHR rats
The basal MAP recorded in SHR- and WKY-anesthetized rats
after the stabilization period and before the administration of
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Table 1
Isoquercitrin content of HETM and TMLR from Tropaeolum majus.
Sample Isoquercitrin contenta
HETM 38.64 (0.30)
TMLR 93.45 (2.80)Fig. 1. ESI(−)-MS ﬁngerpr
ny drug was 134.4±1.8mmHg and 108.9±1.3mmHg, respec-
ively. A pronounced antihypertensive and hypotensive effect
f intraduodenal administration of TMLR (50mg/kg) or HETM
100mg/kg) was observed in both SHR and WKY (Fig. 4A and
), with MAP reduction in the hypertensive rats of 18.77±4.43
nd 14.14±6.7mmHg, respectively. Similar to the absence
f inﬂuence seen in normotensive Wistar rats, HETM and
MLR did not change the heart rate in SHR or WKY animals
Table 2).
.4. Hypotensive effects of Isoquercitrin and kaempferol in
ormotensive rats
The intravenous administration of isoquercitrin (0.5–4mg/kg),
ut not kaempferol, caused a dose-dependent reduction in MAP
Fig. 5A and B), with minor (not statistically signiﬁcant) effects
n heart rate (Table 2). Doses at 2 and 4mg/kg of isoquercitrin
ere able to induce signiﬁcant hypotension (Fig. 5B), with values
f 16.4±4.3 and 23.2±3.7mmHg, respectively.a Isoquercitrin content (mean of triplicate analysis), expressed as mg/g of dried
extract or fraction (% RSD, relative standard deviation).
3.5. Measurement of serum ACE activity
The oral administration of HETM (0–300mg/kg), semi-puriﬁed
fraction (25–100mg/kg) or isoquercitrin (5–10mg/kg) signiﬁcantly
reduced the serum activity of ACE at 1.5h after administration,
when compared to control group (Fig. 6A–C). There was no signiﬁ-
cant difference inACE activity in the group treatedwith kaempferol
when compared to control animals (Fig. 6D). The percentage of ACE
inhibition activity inHETM-treated groupswas 24±5% and20±4%
at 300 and 100mg/kg, respectively (Fig. 6A). In normotensive rats
A. Gasparotto Junior et al. / Journal of Ethnopharmacology 134 (2011) 363–372 367
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Fig. 2. HPLC chromatograms of iso
reated with TMLR at 100 and 50mg/kg, ACE activity was reduced
y 30±8% and 28±7%, respectively (Fig. 6B). Similar to captopril
reduced at 45±5%), a reference ACE inhibitor, a single dose of iso-
uercitrin 5 and 10mg/kg decreases ACE activity, when compared
ith to the control at 1.5h after treatment (Fig. 6C). The percent-
ge decrease of ACE activity in the isoquercitrin-treated group was
4±4% and 22±8% at doses 10 and 5mg/kg, respectively.tes
25 30 35 40 45
itrin (A), HETM (B) and TMLR (C).
3.6. Effects of isoquercitrin administration in MAP changes, and
the time course response of angiotensin I and bradykininThe intravenous administration of isoquercitrin (4mg/kg)
caused a signiﬁcant reduction (34±3%) in the hypertensive
response of angiotensin I in normotensive rats (Fig. 7A). Similarly,
the time course of the hypertensive response was signiﬁcantly
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Fig. 4. Antihypertensive and hypotensive effects of HETM (A) and TMLR (B) obtained
intraduodenal treatment with HETM (A) or TMLR (B). The antihypertensive and hypot
distilled water (open bars) or extracts (closed bars). The results are the mean± S.E.M. o
t-test. *p<0.05, **p<0.01 and ***p<0.001 when compared with the respective control gro
Table 2
Heart rate (beats per minute) of anesthetized rats treated with HETM, TMLR and
isoquercitrin.
Treatment Normotensive SHR
Control 271 ± 19 (6) 340±16 (6)
HETM (100mg/kg) 257 ± 22 (6) 310±14 (6)
HETM (300mg/kg) 246 ± 14 (6) n.e.
TMLR (50mg/kg) 257 ± 19 (6) 313±18 (6)
TMLR (100mg/kg) 238 ± 25 (6) n.e.
Isoquercitrin (2mg/kg) 265 ± 21 (6) n.e.
Isoquercitrin (4mg/kg) 233 ± 17 (6) n.e.
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et al., 2000; Grifﬁths et al., 2001; Kjaer et al., 1978; Lykkesfeldthe values are the mean± S.E.M. of heart rate after administration of HETM, TMLR
r isoquercitrin. The number of experiments per group is showed in parentheses.
n.e.” indicates that the speciﬁc dose was not evaluated in the respective group.
educed in comparisonwith the control group (Fig. 7B) (2.28±0.17
nd3.12±0.17min, respectively). Doses at 4mg/kg of isoquercitrin
id not cause any signiﬁcant change in the hypotensive effects
f bradykinin (30nmol/kg) (Fig. 7A). However, the time course of
he hypotensive response was signiﬁcantly increased when com-
ared to the control group (Fig. 7B) (4.91±0.27and3.10±0.26min,
espectively).
. DiscussionThe fresh leaves and preparations obtained from Tropaeolum
ajus have been used for both nutritional and medicinal purposes
nBrazil. In Brazilian folkmedicine it is commonly indicated against
ardiovascular disorders, such as hypertension, without descrip-from Tropaeolum majus in SHR and WKY rats. The animals were subjected to an
ensive effects were measured in these animals after 30min of administration of
f six experiments in each group. Statistical analyses were performed by Student’s
up.
tion of side effects (Ferreira et al., 2004; Ferro, 2006; Lorenzi and
Matos, 2002). However, the efﬁcacy of Tropaeolum majus as an anti-
hypertensive agent has never been investigated. We have recently
showed that the hydroethanolic extract obtained from Tropaeolum
majus leaves, which contains high levels of ﬂavonoids, possesses
natriuretic and diuretic effects when orally administered in nor-
motensive rats, without acute toxicity or interference in renal
functions (Gasparotto Junior et al., 2009). Based on these ﬁnd-
ings, we investigated the effects of preparations obtained from
Tropaeolum majus in the arterial pressure of both normotensive
and hypertensive (SHR) animals. Our results revealed that the
hydroethanolic extract of Tropaeolum majus (HETM), as well as its
semi-puriﬁed fraction (TMLR), are able todose-dependently reduce
themean arterial pressure of normotensive and SHR animals (max-
imal hypotensive effect ∼15–20mmHg) when administered by
intraduodenal route. Importantly, at least based in our experi-
ments, the reduction inbloodpressure cannotbedirectly attributed
to any cardiac effect of these preparations, since the hypoten-
sion measured after HETM or TMLR administration have not been
accompanied by any signiﬁcant reduction in the heart rate of the
animals tested.
Previous phytochemical studies showed that themajormetabo-
lites in the leaves of Tropaeolum majus are glucosinolates and
polyphenols, including ﬂavonoids and terpenoids (De Medeirosand Moller, 1993; Mietkiewska et al., 2004). Using HPLC and ESI-
MS techniques we veriﬁed that both HETM and TMLR present
high levels of ﬂavonols isoquercitrin and kaempferol glycoside
(Gasparotto Junior et al., in press). Considering the lack of biolog-
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nalyses were performed by means of one-way analysis of variance (ANOVA), follo
hen compared to control group.
cal activities attributed to glucosinolates (Wielanek and Urbanek,
006), we hypothesized that these polyphenolic compounds could
e responsible for the hypotensive effects elicited by HETM and
MLR. In fact, the intravenous administration of low doses of iso-
uercitrin (but not kaempferol) administration was able to cause
signiﬁcant drop in the mean arterial pressure of anesthetized/kg). The results are the mean± S.E.M. of six experiments in each group. Statistical
by t-tests subjected to Bonferroni’s correction. *p<0.05, **p<0.01 and ***p<0.001
rats (∼25mmHg), remembering the effect of HETM and TMLR in
blood pressure. Several ﬂavonoids have been shown as cardiopro-
tective and hypotensive agents in animal models (Jadhav et al.,
2010; Pechanova et al., 2006;Wright et al., 2007; Yung et al., 2008).
Isoquercitrin or plants containing high amounts of this ﬂavonol
are described as able to stabilize atherosclerotic plaques (Enkhmaa
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n anesthetized rats. The control group indicates the effect measured before admin
ere performed by t-tests. *p<0.05, **p<0.01 and ***p<0.001 when compared to c
t al., 2005; Motoyama et al., 2009). In addition, different stud-
es have evidenced antioxidant effects of isoquercitrin (Kim et al.,
007; Silva et al., 2009; Vitor et al., 2004). Although these actions
ay be related to protective cardiovascular events, this is the ﬁrst
tudy demonstrating that isoquercitrin, acutely administered, is
lso able to reducebloodpressure. Thepolyphenolic compound iso-
uercitrin is a ﬂavonol glycoside (quercetin-3-O-glycoside) found
n abundance in several edible and medicinal plants. It is relatively
oluble and has an high absorption rate by the gastrointestinal tract
Chang et al., 2005). Since isoquercitrinwas found as themain com-
ound in the semi-puriﬁed fraction of HETM, we suggest that the
nti-hypertensive effects popularly attributed to Tropaeolum majus
ay be related, at least in part, to the presence of isoquercitrin in
his plant.
A few reports have suggested that aqueous solutions obtained
rom aerial parts of Tropaeolum majus present a weak in vitro ACE
nhibitory activity (Han et al., 1991). Likewise, isoquercitrin was
escribed as a possible inhibitor of ACE activity in vitro (Lacaille
t al., 2001). ACE is a decapeptidyl peptidase (protease) that is
idely distributed in the cardiovascular systemand in various non-
ardiovascular tissues. One of the main locations of the enzyme is
he serum and the vasculature, where activity of ACE promotes
ellular proliferation (Li et al., 1997). In addition, local ACE in
he kidney causes angiotensin II production, which contributes to
educing the urinary excretion of water and sodium, thereby play-
ng an important role in the long-term stabilization of hypertension
Khosla et al., 2009). ACE is a zinc-containing peptidyl dipeptide
ydrolase (Strittmatter and Snyder, 1986). The active site of ACE is
nown to consist of three parts: a carboxylate-binding function-
lity, such as the guanidinium group of arginine; a pocket that
ccommodates a hydrophobic side chain of C-terminal amino acid
esidues; and a zinc ion. The zinc ion coordinates to the carbonyl
f the penultimate peptide bond of the substrate, whereby the car-
onyl group becomes polarized and is subjected to a nucleophilic
ttack. Therefore, some ﬂavonoids (Wagner and Elbl, 1992) were
uggested to show an in vitro activity via the generation of chelate
omplexes within the active centre of ACE. Free hydroxyl groups
f phenolic compounds are also suggested to be important struc-
ural moieties to chelate the zinc ions, thus inactivating the ACE
ctivity (Chen et al., 1992). Given that the ﬂavonols contain aro-
atic hydroxyl groups, it is possible that these functional groups
ay demonstrate an ACE inhibitory activity due to the generation
f chelate complexeswith zinc ionswithin the active center of ACE.se (B) of angiotensin I and bradykinin. All substances tested were administered i.v.
on of ISQ (4mg/kg). The results show the mean± S.E.M. (n=6). Statistical analyses
l group.
In fact, several ﬂavonoids have proven to competitively inhibit ACE
activity (Barbosa-Filho et al., 2006; Kwon et al., 2010; Somanadhan
et al., 1999).
Our study reveals that isoquercitrin may be included in the
group of ﬂavonoids able to inhibit the production of angiotensin
II by ACE seen ex vivo, as found using plasma samples obtained
from isoquercitrin treated rats. In addition, inhibition of ACE was
also demonstrated in vivo, since a single administration of iso-
quercitrin reduced the hypertension induced by angiotensin I
(that results from its conversion to angiotensin II by ACE), and
enhanced the hypotensive action of bradykinin, a B2 receptor ago-
nist that is physiologically degradated through the activity of the
angiotensin converting enzyme. It is well known that activation
of bradykinin B2 receptors may release endothelial agents such
as nitric oxide and prostacyclin, contributing to the blood pres-
sure control and cardiovascular beneﬁts associated with currently
used ACE inhibitors. In addition, the increased half-life of endoge-
nous bradykinin promoted by ramiprilat may be responsible for
the natriuretic effect generated by this ACE inhibitor (Sakamoto
et al., 1994). Importantly, angiotensin II stimulates the release
of aldosterone by supra-renal gland, regulating the action of this
hormone in the control of body and plasmatic volumes. Thus, inhi-
bition of ACE also reduces the reabsorption of sodium and water
by kidneys, increasing diuresis and reducing the blood volume.
This diuretic-like effect of ACE inhibitors is putatively respon-
sible for at least part of the anti-hypertensive effects of these
drugs. As aforementioned, it has been previously demonstrated
that the hydroalcoholic extract from Tropaeolum majus has diuretic
properties when acutely or daily administered in rats. Since iso-
quercitrin is the major ﬂavonoid in Tropaeolum majus, it is likely
that the hypotensive effect of isoquercitrin and also from HETM
might be related, at least in part, with a diuretic action of this
ﬂavonol. To check this hypothesis experiments to evaluate the
diuretic properties of isoquercitrin, as well as the importance of
ACE inhibition in this effect, are being carried out in our labora-
tory.
Although our results strongly suggest that the antihyperten-
sive effect of Tropaeolum majus may be, at least in part, due to an
inhibitory effect of ACE by isoquercitrin, the single administration
ofHETM,or its semi-puriﬁed fractionTMLR, aswell as isoquercitrin,
did not result in any signiﬁcant reduction of heart rate, an hallmark
effect of ACE inhibitors (Pierdomenico et al., 2002). Under the light
of our results we are unable to explain why heart rate remained
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nchanged after ACE inhibition by isoquercitrin. However, it iswell
nown that the full cardiovascular effects of ACE inhibitors may
ake several months to show up and the results found in our study
ere obtained after a single administration of isoquercitrin. On the
ther hand, bothHETMand TMLRhad their potency as hypotensive
gentsmuchmoreevident in SHR than inWKYrats.Hypertension is
requently associated with an increased sympathetic regulation of
he vascular tone, besides neurohumoral and renal abnormalities
Sarikonda et al., 2009). Angiotensin II acts stimulating the sym-
athetic control of the vascular function and ACE inhibitors have a
ajor impact controlling these changes. Taken together, these data
uggest that inhibition of ACE by isoquercitrin may be taking place
lso in the central nervous system.
. Conclusion
Our results show that the hypotensive effects caused by the
ydroethanolic extract of Tropaeolum majus (HETM), as well as its
emi-puriﬁed fraction (TMLR),may be associatedwith the high lev-
ls of the ﬂavonoid isoquercitrin found in this plant. In addition,
soquercitrin-induced hypotension in rats is an event dependent
n the inhibition of angiotensin II generation by ACE. Given
hat common clinical strategies to achieve a lowering of blood
ressure include the use of diuretics and inhibitors of angiotensin-
onverting enzyme in monotherapy or in association (Gallagher
t al., 2006), our ﬁndings have highlighted the therapeutic poten-
ial of Tropaeolum majus as a phytomedicine and the importance of
ubstances present in this plant for the treatment of cardiovascular
iseases.
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